Press "Enter" to skip to content

New patent expiration for Astellas drug ASTAGRAF XL

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astellas drug ASTAGRAF XL

Annual Drug Patent Expirations for ASTAGRAF+XL
Annual Drug Patent Expirations for ASTAGRAF+XL

Astagraf Xl is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-four patent family members in thirty-two countries.

The generic ingredient in ASTAGRAF XL is tacrolimus. One supplier is listed for this compound. Additional details are available on the tacrolimus profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astellas drug ASTAGRAF XL
    Do NOT follow this link or you will be banned from the site!